Gastrointestinal (GI): NSAIDs that block COX-one action have correlations with GI complications because of the inhibition with the synthesis of gastroprotective brokers which include PGE2 and various prostaglandins. This inhibition leads to decreased mucin manufacturing by gastric epithelial cells, significantly less bicarbonate secretion, and fewer epithelial cell turnover, among other https://alfredz354szc2.laowaiblog.com/profile